Ionis Pharmaceuticals | IONS

Stock Price
41.81
Daily Change
-0.65 -1.53%
Monthly
-5.21%
Yearly
16.95%
Q2 Forecast
42.52
Peers Price Chg Day Year Date
068270 Celltrion 176,600.00 -800.00 -0.45% 8.21% Apr/26
1093 Cspc Pharmaceutical 6.60 0.08 1.23% -15.71% Apr/26
1177 Sino Biopharmaceutical 2.77 0.03 1.09% -35.43% Apr/26
4503 Astellas Pharma 1,505.00 52.00 3.58% -24.03% Apr/26
600436 Zhangzhou Pientzehuang Pharmaceutical 225.69 5.46 2.48% -16.22% Apr/26
600518 Kangmei Pharma 2.00 0.07 3.63% -4.31% Apr/26
AGIO Agios Pharmaceuticals 31.67 0 0% 43.30% Apr/25
AIP Adcock Ingram Holdings 5,587.00 37.00 0.67% 11.52% Apr/26
ALNY Alnylam Pharmaceuticals 143.70 -0.09 -0.06% -27.25% Apr/25
ARWR Arrowhead Research 21.85 -1.45 -6.22% -38.49% Apr/25
BMRN BioMarin Pharmaceutical 82.17 -9.07 -9.94% -11.65% Apr/25
EOF Ecofibre 0.06 0 0% -67.03% Apr/24
EXEL Exelixis 23.53 -0.18 -0.76% 27.53% Apr/25
GUD Knight Therapeutics 5.69 -0.03 -0.52% 18.54% Apr/25
HALO Halozyme Therapeutics 38.46 -0.66 -1.69% 17.04% Apr/25
IONS Ionis Pharmaceuticals 41.81 -0.65 -1.53% 16.95% Apr/25
MLC Malin Corporation 5.50 -0.10 -1.79% 14.58% Apr/25
MRNA Moderna 106.22 -2.79 -2.56% -18.75% Apr/25
MVP Medical Developments International 0.54 -0.02 -3.57% -46.00% Apr/26
NBIX Neurocrine Biosciences 137.73 -1.24 -0.89% 34.08% Apr/25
NEU Neuren Pharmaceuticals 18.65 -0.20 -1.06% 30.42% Apr/26
NOVN Novartis 89.31 -0.70 -0.77% -2.24% Apr/26
OGI Organigram Holdings 2.56 -0.10 -3.76% 276.47% Apr/25
OPK OPKO Health 459.80 -18.10 -3.79% -11.10% Apr/25
PBP Probiotec 2.83 -0.01 -0.35% 19.92% Apr/26
PFE Pfizer 25.26 -0.97 -3.69% -34.61% Apr/25
PHM Pharma Mar 28.60 -0.22 -0.76% -22.37% Apr/26
PTCT PTC Therapeutics 25.49 0.28 1.11% -51.21% Apr/25
QIA Qiagen NV 38.34 0.40 1.05% -3.99% Apr/26
RARE Ultragenyx Pharmaceutical 43.85 -0.41 -0.93% 3.59% Apr/25
REGN Regeneron Pharmaceuticals 906.54 -16.99 -1.87% 16.52% Apr/25
ROG Roche Holding 219.20 0.40 0.18% -20.64% Apr/26
ROVI Laboratorios Farma 83.88 -0.83 -0.97% 107.82% Apr/26
SRPT Sarepta Therapeutics 127.41 3.16 2.54% 4.20% Apr/25
SRT3 Sartorius 290.10 8.00 2.84% -16.71% Apr/26
TRLY Tilray 2.41 -0.11 -4.37% -18.31% Apr/25
VRTX Vertex Pharmaceuticals 397.24 -3.35 -0.84% 22.87% Apr/25

Ionis Pharmaceuticals traded at $41.81 this Thursday April 25th, decreasing $0.65 or 1.53 percent since the previous trading session. Looking back, over the last four weeks, Ionis Pharmaceuticals lost 5.21 percent. Over the last 12 months, its price rose by 16.95 percent. Looking ahead, we forecast Ionis Pharmaceuticals to be priced at 42.52 by the end of this quarter and at 40.13 in one year, according to Trading Economics global macro models projections and analysts expectations.

Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company is primarily focused on two core franchises: neurology and cardiometabolic. Its products include SPINRAZA, TEGSEDI and WAYLIVRA. SPINRAZA is for treatment of patients of all ages with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. TEGSEDI is for the treatment of patients with polyneuropathy caused by hereditary transthyretin (TTR), amyloidosis (hATTR), a debilitating, progressive, and fatal disease. Its products in pipeline include tofersen for SOD1-ALS, eplontersen (IONIS-TTR-LRX) for TTR, IONIS-APOCIII-LRx for familial chylomicronemia syndrome (FCS), pelacarsen for lipoprotein(a) (Lp), driven cardiovascular disease and ION363 for amyotrophic lateral sclerosis (ALS), with mutations in the fused in sarcoma gene (FUS).